$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

$uavs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000165495423006392 Filed on May 15, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$4.057M	$3.842M
YoY Change	5.6%	125.79%
Cost Of Revenue	$2.078M	$2.477M
YoY Change	-16.09%	298.31%
Gross Profit	$1.979M	$1.365M
YoY Change	44.97%	26.41%
Gross Profit Margin	48.77%	35.53%
Selling, General & Admin	$4.557M	$6.616M
YoY Change	-31.12%	73.75%
% of Gross Profit	230.33%	484.73%
Research & Development	$1.582M	$2.185M
YoY Change	-27.58%	838.54%
% of Gross Profit	79.97%	160.08%
Depreciation & Amortization	$100.7K	$876.0K
YoY Change	-88.5%	548.35%
% of Gross Profit	5.09%	64.18%
Operating Expenses	$6.140M	$8.847M
YoY Change	-30.6%	118.95%
Operating Profit	-$4.161M	-$7.482M
YoY Change	-44.38%	152.7%
Interest Expense	-$305.5K	-$16.33K
YoY Change	1770.79%	-672.98%
% of Operating Profit
Other Income/Expense, Net	-$438.4K	-$98.30K
YoY Change	345.97%	-458.5%
Pretax Income	-$4.599M	-$7.597M
YoY Change	-39.45%	159.22%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$4.599M	-$7.597M
YoY Change	-39.45%	159.22%
Net Earnings / Revenue	-113.37%	-197.73%
Basic Earnings Per Share	-$1.03
Diluted Earnings Per Share	-$0.05	-$97.49K
COMMON SHARES
Basic Shares Outstanding	4.483M shares
Diluted Shares Outstanding	4.483M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.848M	$9.187M
YoY Change	-69.0%	-62.03%
Cash & Equivalents	$2.848M	$9.187M
Short-Term Investments
Other Short-Term Assets	$838.5K	$1.433M
YoY Change	-41.47%	406.46%
Inventory	$6.584M	$5.309M
Prepaid Expenses	$838.5K
Receivables	$2.911M	$3.105M
Other Receivables	$185.0K	$185.0K
Total Short-Term Assets	$13.37M	$19.22M
YoY Change	-30.45%	-26.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$700.1K	$2.644M
YoY Change	-73.52%	84.11%
Goodwill	$23.18M
YoY Change
Intangibles	$10.86M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.9K	$280.9K
YoY Change	7.81%	1023.76%
Total Long-Term Assets	$38.82M	$81.08M
YoY Change	-52.12%	197.61%
TOTAL ASSETS
Total Short-Term Assets	$13.37M	$19.22M
Total Long-Term Assets	$38.82M	$81.08M
Total Assets	$52.19M	$100.3M
YoY Change	-47.97%	87.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.467M	$1.924M
YoY Change	-23.72%	290.23%
Accrued Expenses	$331.0K	$2.950M
YoY Change	-88.78%	-22.91%
Deferred Revenue	$554.9K
YoY Change
Short-Term Debt	$933.7K	$0.00
YoY Change
Long-Term Debt Due	$451.1K	$445.8K
YoY Change	1.2%	332.96%
Total Short-Term Liabilities	$5.233M	$16.12M
YoY Change	-67.53%	77.75%
LONG-TERM LIABILITIES
Long-Term Debt	$406.4K	$802.7K
YoY Change	-49.38%	17816.96%
Other Long-Term Liabilities	$2.998M	$5.014M
YoY Change	-40.2%	-14.94%
Total Long-Term Liabilities	$406.4K	$5.817M
YoY Change	-93.01%	-1.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.233M	$16.12M
Total Long-Term Liabilities	$406.4K	$5.817M
Total Liabilities	$10.02M	$21.93M
YoY Change	-54.31%	46.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$116.4M
YoY Change
Common Stock	$90.77K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$42.17M	$78.37M
YoY Change
Total Liabilities & Shareholders Equity	$52.19M	$100.3M
YoY Change	-47.97%	87.49%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.599M	-$7.597M
YoY Change	-39.45%	159.22%
Depreciation, Depletion And Amortization	$100.7K	$876.0K
YoY Change	-88.5%	548.35%
Cash From Operating Activities	-$4.235M	-$6.510M
YoY Change	-34.96%	476.86%
INVESTING ACTIVITIES
Capital Expenditures	$5.337K	-$74.95K
YoY Change	-107.12%	-9.69%
Acquisitions
YoY Change
Other Investing Activities	-$248.9K	-$3.428M
YoY Change	-92.74%	-74.02%
Cash From Investing Activities	-$254.2K	-$3.503M
YoY Change	-92.74%	-73.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.000M	4.614M
YoY Change	-34.98%	-68.53%
NET CHANGE
Cash From Operating Activities	-$4.235M	-6.510M
Cash From Investing Activities	-$254.2K	-3.503M
Cash From Financing Activities	$3.000M	4.614M
Net Change In Cash	-$1.502M	-5.399M
YoY Change	-72.18%	-2232.38%
FREE CASH FLOW
Cash From Operating Activities	-$4.235M	-$6.510M
Capital Expenditures	$5.337K	-$74.95K
Free Cash Flow	-$4.240M	-$6.435M
YoY Change	-34.12%	515.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000008504
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90771375	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88466613	shares
CY2020Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	500000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1847200	shares
CY2023Q1	uavs	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Terms ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerms	P5Y
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2381	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	0	shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36492
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AGEAGLE AERIAL SYSTEMS INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0422242
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8863 E. 34th Street North
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wichita
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	67226
CY2023Q1	dei	City Area Code CityAreaCode	620
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	325-6363
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	UAVS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	92321375	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2847908	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4349837	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2910500	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6583888	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	838495	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1029548	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	13365791	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14463272	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	700079	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3783318	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10855866	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2023Q1	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	302875	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	291066	usd
CY2023Q1	us-gaap	Assets Assets	52187340	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1467193	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1845135	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1205554	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1680706	usd
CY2023Q1	uavs	Promissory Note Net Of Debt Discount PromissoryNoteNetOfDebtDiscount	933694	usd
CY2022Q4	uavs	Promissory Note Net Of Debt Discount PromissoryNoteNetOfDebtDiscount	287381	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	554926	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	620973	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q1	uavs	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	451144	usd
CY2022Q4	uavs	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	446456	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5233484	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5384181	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2998202	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	406354	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	446813	usd
CY2023Q1	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	0	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	106163	usd
CY2023Q1	uavs	Long Term Portion Of Promissory Note Net Of Debt Discount LongTermPortionOfPromissoryNoteNetOfDebtDiscount	1384112	usd
CY2022Q4	uavs	Long Term Portion Of Promissory Note Net Of Debt Discount LongTermPortionOfPromissoryNoteNetOfDebtDiscount	1861539	usd
CY2023Q1	us-gaap	Liabilities Liabilities	10022152	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10960399	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90771375	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88466613	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	90772	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	88467	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158378640	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154679363	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116408919	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111553444	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	104687	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10083	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	42165188	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52187340	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54184874	usd
CY2023Q1	us-gaap	Revenues Revenues	4057069	usd
CY2022Q1	us-gaap	Revenues Revenues	3841978	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2078437	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2477086	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1978632	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1364892	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3579522	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5481380	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1582343	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2184924	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	977875	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1180529	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6139740	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	8846833	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4161108	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7481941	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-305497	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-16332	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-132894	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-98299	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-438391	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-114631	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4599499	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7596572	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	uavs	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-4599499	usd
CY2022Q1	uavs	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-7596572	usd
CY2023Q1	uavs	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.05
CY2022Q1	uavs	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.10
CY2023Q1	uavs	Weighted Average Number Of Shares Outstanding During Period Basic And Diluted WeightedAverageNumberOfSharesOutstandingDuringPeriodBasicAndDiluted	89649999	shares
CY2022Q1	uavs	Weighted Average Number Of Shares Outstanding During Period Basic And Diluted WeightedAverageNumberOfSharesOutstandingDuringPeriodBasicAndDiluted	77923660	shares
CY2023Q1	uavs	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-4599499	usd
CY2022Q1	uavs	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-7596572	usd
CY2023Q1	uavs	Amortization Of Unrecognized Periodic Pension Cost AmortizationOfUnrecognizedPeriodicPensionCost	43345	usd
CY2022Q1	uavs	Amortization Of Unrecognized Periodic Pension Cost AmortizationOfUnrecognizedPeriodicPensionCost	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	51259	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	20172	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4504895	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7576400	usd
CY2023Q1	uavs	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-66921	usd
CY2022Q1	uavs	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	0	usd
CY2023Q1	uavs	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-255976	usd
CY2022Q1	uavs	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	0	usd
CY2023Q1	uavs	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-4827792	usd
CY2022Q1	uavs	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-7576400	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023Q1	uavs	Issuance Of Preferred Stock Series F Convertible Net Of Issuance Cost Amount IssuanceOfPreferredStockSeriesFConvertibleNetOfIssuanceCostAmount	3000000	usd
CY2023Q1	uavs	Conversion Of Preferred Stock Series F Convertible Shares To Common Stock Amount ConversionOfPreferredStockSeriesFConvertibleSharesToCommonStockAmount	0	usd
CY2023Q1	uavs	Dividends On Series F Preferred Stock DividendsOnSeriesFPreferredStock	-66921	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	512529	usd
CY2023Q1	uavs	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	43345	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	51259	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4599499	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	42165188	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76576913	usd
CY2022Q1	uavs	Sales Of Common Stock Net Of Issuance Costs Amount SalesOfCommonStockNetOfIssuanceCostsAmount	4583341	usd
CY2022Q1	uavs	Issuance Of Common Stock For Sensefly Acquisition Amount IssuanceOfCommonStockForSenseflyAcquisitionAmount	3000000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30750	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1753881	usd
CY2022Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	20172	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7596572	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	78368485	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4599499	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	7596572	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	512529	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1753881	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1001338	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	875990	usd
CY2023Q1	us-gaap	Defined Benefit Plan Other Changes DefinedBenefitPlanOtherChanges	148764	usd
CY2022Q1	us-gaap	Defined Benefit Plan Other Changes DefinedBenefitPlanOtherChanges	7992	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	168885	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	684800	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	232756	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-138756	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1287229	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-228733	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	144118	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-383607	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-594938	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-547170	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-105019	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	56577	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	828410	usd
CY2023Q1	uavs	Increase Decrease In Covid Loan IncreaseDecreaseInCovidLoan	-44598	usd
CY2022Q1	uavs	Increase Decrease In Covid Loan IncreaseDecreaseInCovidLoan	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	67094	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4234526	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6510343	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5337	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74951	usd
CY2023Q1	uavs	Acquisition Of Sensefly Net Of Cash Acquired AcquisitionOfSenseflyNetOfCashAcquired	0	usd
CY2022Q1	uavs	Acquisition Of Sensefly Net Of Cash Acquired AcquisitionOfSenseflyNetOfCashAcquired	489989	usd
CY2023Q1	uavs	Acquisition Of Micasense Net Of Cash Acquired AcquisitionOfMicasenseNetOfCashAcquired	0	usd
CY2022Q1	uavs	Acquisition Of Micasense Net Of Cash Acquired AcquisitionOfMicasenseNetOfCashAcquired	2446512	usd
CY2023Q1	uavs	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	139509	usd
CY2022Q1	uavs	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	319799	usd
CY2023Q1	uavs	Capitalization Of Internal Use Software Costs CapitalizationOfInternalUseSoftwareCosts	109345	usd
CY2022Q1	uavs	Capitalization Of Internal Use Software Costs CapitalizationOfInternalUseSoftwareCosts	171907	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-254191	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3503158	usd
CY2023Q1	uavs	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	0	usd
CY2022Q1	uavs	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	4583341	usd
CY2023Q1	uavs	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	3000000	usd
CY2022Q1	uavs	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30750	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4614091	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-13212	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4517	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1501929	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5403927	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4349837	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14590566	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2847908	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9186639	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	uavs	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	2305	usd
CY2022Q1	uavs	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	0	usd
CY2023Q1	uavs	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	66921	usd
CY2022Q1	uavs	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	0	usd
CY2023Q1	uavs	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	255976	usd
CY2022Q1	uavs	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	0	usd
CY2023Q1	uavs	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition	0	usd
CY2022Q1	uavs	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition	3000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4599499	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4234526	usd
CY2023Q1	uavs	Working Capital WorkingCapital	8132307	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116408919	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px"><em>Use of Estimates </em>– The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the reserve for obsolete inventory, valuation of stock issued for services and stock options, valuation of intangible assets, and the valuation of deferred tax assets.</p>
CY2023Q1	uavs	Shipping Costs ShippingCosts	64936	usd
CY2022Q1	uavs	Shipping Costs ShippingCosts	59458	usd
CY2023Q1	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	554926	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	496390	usd
CY2023Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1306380	usd
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1332516	usd
CY2023Q1	uavs	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	751976	usd
CY2022Q4	uavs	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	721795	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	40689	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	60626	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2927417	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2229840	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	16917	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	16800	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2910500	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4455666	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5288206	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	898614	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1106056	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1554238	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	614400	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	6908518	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	7008662	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	324630	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	322815	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6583888	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	226177	usd
CY2022Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	281484	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	208144	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	184429	usd
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	156914	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	234691	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	92734	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	167794	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	90165	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	99558	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	64361	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61592	usd
CY2023Q1	uavs	Prepaid And Other Current Assets PrepaidAndOtherCurrentAssets	838495	usd
CY2022Q4	uavs	Prepaid And Other Current Assets PrepaidAndOtherCurrentAssets	1029548	usd
CY2023Q1	uavs	Leasehold Improvements LeaseholdImprovements	106837	usd
CY2022Q4	uavs	Leasehold Improvements LeaseholdImprovements	106837	usd
CY2023Q1	uavs	Production Tools And Equipment ProductionToolsAndEquipment	638575	usd
CY2022Q4	uavs	Production Tools And Equipment ProductionToolsAndEquipment	632514	usd
CY2023Q1	uavs	Computer And Office Equipment ComputerAndOfficeEquipment	515010	usd
CY2022Q4	uavs	Computer And Office Equipment ComputerAndOfficeEquipment	507637	usd
CY2023Q1	uavs	Furniture Furniture	77486	usd
CY2022Q4	uavs	Furniture Furniture	77799	usd
CY2023Q1	uavs	Drone Equipment DroneEquipment	170109	usd
CY2022Q4	uavs	Drone Equipment DroneEquipment	170109	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1508017	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1494896	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	807938	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	703741	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	700079	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q1	us-gaap	Depreciation Depreciation	100697	usd
CY2022Q1	us-gaap	Depreciation Depreciation	110735	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11507653	usd
CY2023Q1	uavs	Additions Additions	248854	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-900641	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10855866	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P4Y6M10D
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	900641	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	765255	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2613206	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2775753	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1547669	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1167169	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1158057	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1594012	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10855866	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	251647	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	774916	usd
CY2023Q1	uavs	Provision For Warranty Expense ProvisionForWarrantyExpense	289304	usd
CY2022Q4	uavs	Provision For Warranty Expense ProvisionForWarrantyExpense	288807	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	244155	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	262737	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	89444	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	331004	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	354246	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1205554	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1680706	usd
CY2020Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	500000	usd
CY2023Q1	uavs	Good Faith Acquisition Ofconsideration GoodFaithAcquisitionOfconsideration	15000000	usd
CY2021Q4	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	315000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability	0	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability	23798	usd
CY2023Q1	uavs	Less Current Portion Business Acquisition Agreementrelated Liabilities LessCurrentPortionBusinessAcquisitionAgreementrelatedLiabilities	0	usd
CY2022Q4	uavs	Less Current Portion Business Acquisition Agreementrelated Liabilities LessCurrentPortionBusinessAcquisitionAgreementrelatedLiabilities	0	usd
CY2023Q1	uavs	Longterm Portion Of Business Acquisition Agreementrelated Liabilities LongtermPortionOfBusinessAcquisitionAgreementrelatedLiabilities	0	usd
CY2022Q4	uavs	Longterm Portion Of Business Acquisition Agreementrelated Liabilities LongtermPortionOfBusinessAcquisitionAgreementrelatedLiabilities	0	usd
CY2023Q1	uavs	Covid Loan Disclosuretext Block CovidLoanDisclosuretextBlock	<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 6 – COVID Loans</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In connection with the senseFly Acquisition, the Company assumed the obligations for two COVID Loans originally made by the SBA to senseFly S.A. on July 27, 2020 (“senseFly COVID Loans”). As of senseFly Acquisition Date, the fair value of the COVID Loan was $1,440,046 (“senseFly COVID Loans”). For the three months ended March 31, 2023, senseFly S.A. made the required payments on the senseFly COVID Loans, including principal and accrued interest, aggregating approximately $44,598, for the three months ended March 31, 2022, no payments of principal and interest were required. As of March 31, 2023, the Company’s outstanding obligations under the senseFly COVID Loans are $857,498.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">As of March 31, 2023, scheduled principal payments due under the senseFly COVID Loans are as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Year ending December 31,</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023 (rest of year)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">405,993</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90,302</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90,302</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90,302</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">180,599</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">857,498</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1	us-gaap	Loans Assumed1 LoansAssumed1	1440046	usd
CY2022Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	44598	usd
CY2023Q1	uavs	Ppp Loan Amount PppLoanAmount	857498	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	405993	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	90302	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	90302	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	90302	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	180599	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	857498	usd
CY2022Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	3500000	usd
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.44
CY2022Q4	us-gaap	Malpractice Loss Contingency Discount Rate MalpracticeLossContingencyDiscountRate	0.04	pure
CY2022Q4	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.08	pure
CY2022Q4	uavs	Net Proceeds NetProceeds	3285000	usd
CY2022Q4	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	140000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	75000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefits Interest Rate LiabilityForFuturePolicyBenefitsInterestRate	1.358	pure
CY2023Q1	uavs	Share Based Goods And Nonemployee Services Transaction Valuations Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodRiskFreeInterestRate	0.0373	pure
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0	pure
CY2023Q1	uavs	Interest Expense On Debt InterestExpenseOnDebt	168885	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1182194	usd
CY2023Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Additions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions	3300000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	70000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	89444	usd
CY2023Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3500000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1182194	usd
CY2023Q1	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	2317806	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	16129032	shares
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.96
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	565161	usd
CY2023Q1	uavs	Expected Life Of Warrants ExpectedLifeOfWarrants	P3Y
CY2023Q1	uavs	Volatility Volatility	1.31	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0446	pure
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0	pure
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4251151	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	4583341	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	141754	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	512529	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1753881	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1028960	shares
CY2023Q1	uavs	Weighted Average Grant Date Fair Value Vested Beginning WeightedAverageGrantDateFairValueVestedBeginning	2.31
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	649750	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.42
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	55870	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	1.68
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1622840	shares
CY2023Q1	uavs	Weighted Average Grant Date Fair Value Vested Ending WeightedAverageGrantDateFairValueVestedEnding	1.58
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1122984	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.61
CY2023Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfShares	499856	shares
CY2023Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Option Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedWeightedAverageGrantDateFairValue	1.50
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1147250	shares
CY2022Q1	uavs	Weighted Average Grant Date Fair Value Vested Beginning WeightedAverageGrantDateFairValueVestedBeginning	3.78
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	340607	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.26
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	25500	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.94
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1462357	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.21
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	721609	shares
CY2022Q1	uavs	Weighted Average Grant Date Fair Value Vested Ending WeightedAverageGrantDateFairValueVestedEnding	3.74
CY2022Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfShares	740748	shares
CY2022Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Option Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedWeightedAverageGrantDateFairValue	2.69
CY2023Q1	uavs	Share Based Compensation Arrangement Beginning Balance ShareBasedCompensationArrangementBeginningBalance	2561231	shares
CY2023Q1	uavs	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	2.18
CY2023Q1	uavs	Weighted Average Fair Value Opening Balance WeightedAverageFairValueOpeningBalance	1.19
CY2023Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Beg Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualBegTerm	P3Y3M29D
CY2023Q1	uavs	Aggregate Intrinsic Value Outstanding Beginning Balance AggregateIntrinsicValueOutstandingBeginningBalance	31124	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	150000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.45
CY2023Q1	uavs	Weighted Average Fair Value Granted WeightedAverageFairValueGranted	0.21
CY2023Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P3Y7D
CY2023Q1	uavs	Aggregate Intrinsic Value Granted AggregateIntrinsicValueGranted	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2023Q1	uavs	Weighted Avg Exercise Price Excercised WeightedAvgExercisePriceExcercised	0
CY2023Q1	uavs	Weighted Average Fair Value Exercised WeightedAverageFairValueExercised	0
CY2023Q1	uavs	Aggregate Intrinsic Value Exercised AggregateIntrinsicValueExercised	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20688	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.34
CY2023Q1	uavs	Weighted Average Fair Value Expiredforfeited WeightedAverageFairValueExpiredforfeited	3.95
CY2023Q1	uavs	Aggregate Intrinsic Value Cancelled AggregateIntrinsicValueCancelled	0	usd
CY2023Q1	uavs	Share Based Compensation Arrangement Beginning Balance Ending Balance ShareBasedCompensationArrangementBeginningBalanceEndingBalance	2690543	shares
CY2023Q1	uavs	Weighted Average Exercise Price Outstanding Ending Balance WeightedAverageExercisePriceOutstandingEndingBalance	2.05
CY2023Q1	uavs	Weighted Average Fair Value Ending Balance WeightedAverageFairValueEndingBalance	3.19
CY2023Q1	uavs	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual End Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualEndTerm	P3Y9M21D
CY2023Q1	uavs	Aggregate Intrinsic Value Outstanding At End AggregateIntrinsicValueOutstandingAtEnd	93764	usd
CY2023Q1	uavs	Sharebasedcompensationarrangementbysharebasedpaymentending Balance SharebasedcompensationarrangementbysharebasedpaymentendingBalance	2148109	shares
CY2023Q1	uavs	Share Based Compensation Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.34
CY2023Q1	uavs	Weighted Average Fair Value Exercisable WeightedAverageFairValueExercisable	1.28
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M13D
CY2023Q1	uavs	Share Based Compensation Arrangement By Share Based Payment Award Options Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestExercisableAggregateIntrinsicValue	83521	usd
CY2023Q1	us-gaap	Share Price SharePrice	0.45
CY2022Q1	us-gaap	Share Price SharePrice	1.19
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6578	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6918	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0381	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0245	pure
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	261480	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	323573	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3783318	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	620973	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2998202	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	663174	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	946961	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	947497	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	948033	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	731502	usd
CY2023Q1	uavs	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	182875	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4420042	usd
CY2023Q1	uavs	Amount Representing Interest AmountRepresentingInterest	-800867	usd
CY2023Q1	uavs	Present Value Of Future Minimum Lease Payments PresentValueOfFutureMinimumLeasePayments	3619175	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	620973	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2998202	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y7M6D
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2023Q1	uavs	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	261222	usd
CY2022Q1	uavs	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	323573	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	7142715	shares
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.42
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Gross Premium Income AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome	3000000	usd
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5000000	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16129032	shares
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.44
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Gross Premium Income AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome	6774193	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	21129032	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	21129032	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7142715	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.42
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	28271747	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y21D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	23271747	shares
CY2023Q1	uavs	Weighted Average Exercise Price Warrants Exercise Price WeightedAverageExercisePriceWarrantsExercisePrice	0.42
CY2023Q1	uavs	Weighted Average Remaining Contractual Term Outstanding Exercisable WeightedAverageRemainingContractualTermOutstandingExercisable	P2Y11M12D
CY2023Q1	us-gaap	Other Commitment OtherCommitment	2594596	usd

Files In Submission

Name	View Source	Status
uavs-20230331_cal.xml	Edgar Link	unprocessable
0001654954-23-006392-index-headers.html	Edgar Link	pending
0001654954-23-006392-index.html	Edgar Link	pending
0001654954-23-006392.txt	Edgar Link	pending
0001654954-23-006392-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uavs-20230331.xsd	Edgar Link	pending
uavs_10q.htm	Edgar Link	pending
uavs_ex311.htm	Edgar Link	pending
uavs_ex312.htm	Edgar Link	pending
uavs_ex321.htm	Edgar Link	pending
uavs_ex322.htm	Edgar Link	pending
uavs-20230331_def.xml	Edgar Link	unprocessable
uavs-20230331_lab.xml	Edgar Link	unprocessable
uavs-20230331_pre.xml	Edgar Link	unprocessable
uavs_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

2023 Q1 Form 10-Q Financial Statement

#000165495423006392 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS AgEagle Aerial Systems Inc. Stock $uavs

2023 Q1 Form 10-Q Financial Statement

#000165495423006392 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs